PDR001 in Combination With Bevacizumab and mFOLFOX6 as First Line Therapy in Patients With Metastatic MSS Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Metastatic Colorectal Cancer
Related studies linked through entity extraction aliases.
Avelumab and Cetuximab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer - The Phase II AVETUX-CRC Trial.
- Status
- COMPLETED
- Phase
- PHASE2
Olaptesed (NOX-A12) Alone and in Combination With Pembrolizumab in Colorectal and Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Avelumab for MSI-H or POLE Mutated Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
The CHOICE Registry
- Status
- TERMINATED
- Phase
- N/A
Prophylaxis of Magnesium-rich Mineral Water to Prevent Hypomagnesemia Induced by an Anti-EGFR (OPTIMAG)
- Status
- UNKNOWN
- Phase
- NA
Consolidative Radiotherapy Plus Maintenance Chemotherapy for Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Apatinib and Capecitabine Combination to Maintain Treating Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
The Efficacy of Silymarin as Adjuvant Therapy on Colorectal Cancer Patients Undergoing FOLFIRI Treatment
- Status
- COMPLETED
- Phase
- PHASE4
A Clinical Trial of Durvalumab and Tremelimumab, Administered With Radiation Therapy or Ablation in Patients With Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy Intensification in Patients With High Lactate Dehydrogenase Values and Soluble Syndecan1 Levels
- Status
- TERMINATED
- Phase
- PHASE2
Phase Ib Study of PDR001 in Combination With Regorafenib in Adult Patients With Previously Treated Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Validation of a New Prognostic Score for Adult Patients With RAS Wild-type mCRC Treated With Vectibix® and FOLFIRI or FOLFOX in First Line (VALIDATE)
- Status
- COMPLETED
- Phase
- N/A
A Study of OMP-305B83 in Subjects With Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Brontictuzumab With Chemotherapy for Subjects With Previously Treated Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Pharmacokinetics of Recombinant Anti-EGFr Antibody in Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Prospective Translational Study Investigating Molecular Predictors of Resistance and Response to Regorafenib Monotherapy
- Status
- COMPLETED
- Phase
- N/A
High-activity Natural Killer Immunotherapy for Small Metastases of Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
PROSPECT-C: A Study of Biomarkers of Response or Resistance to Anti-EGFR Therapies in Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- N/A
Study of GVAX (With CY) and Pembrolizumab in MMR-p Advanced Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2